Patrick A Ott

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Monoclonal Antibody

Basal Cell Carcinoma

Metastatic Colorectal Cancer

Top Venues

Journal for immunotherapy of cancer

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, Miklos C Fogarasi, Patrick A Ott, F Stephen Hodi, Tamara A Sussman, Ann W Silk, Rizwan Haq, David Liu, Megan Insco, Elizabeth I Buchbinder
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab. Journal for immunotherapy of cancer 12 (8) (2024)
Edward F Fritsch, Patrick A Ott
Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans. Cancer research 84 (7) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, Miklos C Fogarasi, Patrick A Ott, F Stephen Hodi, Tamara A Sussman, Ann W Silk, Rizwan Haq, David Liu, Megan Insco, Elizabeth I Buchbinder
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab. Journal for immunotherapy of cancer 12 (8) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Garrett S Dunlap, Daniel DiToro, Joel Henderson, Sujal I Shah, Mike Manos, Mariano Severgnini, Astrid Weins, Indira Guleria, Patrick A Ott, Naoka Murakami, Deepak A Rao
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy. Nature communications 14 (1) (2023)
Garrett S Dunlap, Daniel DiToro, Joel Henderson, Sujal I Shah, Mike Manos, Mariano Severgnini, Astrid Weins, Indira Guleria, Patrick A Ott, Naoka Murakami, Deepak A Rao
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy. Nature communications 14 (1) (2023)
Garrett S Dunlap, Daniel DiToro, Joel Henderson, Sujal I Shah, Mike Manos, Mariano Severgnini, Astrid Weins, Indira Guleria, Patrick A Ott, Naoka Murakami, Deepak A Rao
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy. Nature communications 14 (1) (2023)
Garrett S Dunlap, Daniel DiToro, Joel Henderson, Sujal I Shah, Mike Manos, Mariano Severgnini, Astrid Weins, Indira Guleria, Patrick A Ott, Naoka Murakami, Deepak A Rao
Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy. Nature communications 14 (1) (2023)
Eryn Blass, Patrick A Ott
PD-1 Inhibition-Trouble for Subsequent TIL Therapy in Patients with Melanoma? Clinical cancer research : an official journal of the American Association for Cancer Research 28 (14) (2022)
Patrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, Evisa Gjini, Kristen D Felt, Jacquelyn O Wolff, Elizabeth I Buchbinder, Rizwan Haq, Ryan J Sullivan, Donald P Lawrence, David F McDermott, Mariano Severgnini, Anita Giobbie-Hurder, Scott J Rodig, F Stephen Hodi
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial. Journal for immunotherapy of cancer 9 (11) (2022)
Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Jeffrey S Wasser, Eric Angevin, Patrick A Ott, Alison Forgie, Wenjing Yang, Cen Guo, Jeffrey Chou, Anthony B El-Khoueiry
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors. Journal for immunotherapy of cancer 10 (10) (2022)
Giacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, J Bryan Iorgulescu, Susan Klaeger, Jacquelyn O Wolff, Suzanna Rachimi, Vipheaviny Chea, Kate Krause, Samuel S Freeman, Wandi Zhang, Shuqiang Li, David A Braun, Donna S Neuberg, Steven A Carr, Kenneth J Livak, Dennie T Frederick, Edward F Fritsch, Megan Wind-Rotolo, Nir Hacohen, Moshe Sade-Feldman, Charles H Yoon, Derin B Keskin, Patrick A Ott, Scott J Rodig, Genevieve M Boland, Catherine J Wu
Landscape of helper and regulatory antitumour CD4 + T cells in melanoma. Nature 605 (7910) (2022)
Zhuting Hu, Donna E Leet, Rosa L Allesøe, Giacomo Oliveira, Shuqiang Li, Adrienne M Luoma, Jinyan Liu, Juliet Forman, Teddy Huang, J Bryan Iorgulescu, Rebecca Holden, Siranush Sarkizova, Satyen H Gohil, Robert A Redd, Jing Sun, Liudmila Elagina, Anita Giobbie-Hurder, Wandi Zhang, Lauren Peter, Zoe Ciantra, Scott Rodig, Oriol Olive, Keerthi Shetty, Jason Pyrdol, Mohamed Uduman, Patrick C Lee, Pavan Bachireddy, Elizabeth I Buchbinder, Charles H Yoon, Donna Neuberg, Bradley L Pentelute, Nir Hacohen, Kenneth J Livak, Sachet A Shukla, Lars Rønn Olsen, Dan H Barouch, Kai W Wucherpfennig, Edward F Fritsch, Derin B Keskin, Catherine J Wu, Patrick A Ott
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma. Nature medicine 27 (3) (2021)
Giacomo Oliveira, Kari Stromhaug, Susan Klaeger, Tomasz Kula, Dennie T Frederick, Phuong M Le, Juliet Forman, Teddy Huang, Shuqiang Li, Wandi Zhang, Qikai Xu, Nicoletta Cieri, Karl R Clauser, Sachet A Shukla, Donna S Neuberg, Sune Justesen, Gavin MacBeath, Steven A Carr, Edward F Fritsch, Nir Hacohen, Moshe Sade-Feldman, Kenneth J Livak, Genevieve M Boland, Patrick A Ott, Derin B Keskin, Catherine J Wu
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma. Nature 596 (7870) (2021)